These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 28843017)
1. Motor hyperactivity of the iron-deficient rat - an animal model of restless legs syndrome. Lai YY; Cheng YH; Hsieh KC; Nguyen D; Chew KT; Ramanathan L; Siegel JM Mov Disord; 2017 Dec; 32(12):1687-1693. PubMed ID: 28843017 [TBL] [Abstract][Full Text] [Related]
2. Striatal mechanism of the restless legs syndrome. Lai YY; Hsieh KC; Chew KT; Nguyen D; Siegel JM Sleep; 2022 Jul; 45(7):. PubMed ID: 35537196 [TBL] [Abstract][Full Text] [Related]
3. Striatal histamine mechanism in the pathogenesis of restless legs syndrome. Lai YY; Hsieh KC; Cheng YH; Chew KT; Nguyen D; Ramanathan L; Siegel JM Sleep; 2020 Feb; 43(2):. PubMed ID: 31671173 [TBL] [Abstract][Full Text] [Related]
4. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome. Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702 [TBL] [Abstract][Full Text] [Related]
5. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance. Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of periodic limb movements in a putative animal model of restless leg syndrome. Lopes C; Esteves AM; Frussa-Filho R; Tufik S; de Mello MT Mov Disord; 2012 Mar; 27(3):413-20. PubMed ID: 22162115 [TBL] [Abstract][Full Text] [Related]
7. Low-dose pramipexole in the management of restless legs syndrome. An open label trial. Stiasny-Kolster K; Oertel WH Neuropsychobiology; 2004; 50(1):65-70. PubMed ID: 15179023 [TBL] [Abstract][Full Text] [Related]
8. Restless legs syndrome as the presenting symptom of multiple myeloma. Aricò D; Raggi A; Siragusa M; Zucconi M; Ferri R J Clin Sleep Med; 2013 Apr; 9(4):383-5. PubMed ID: 23585755 [TBL] [Abstract][Full Text] [Related]
9. Leg movements during wakefulness in restless legs syndrome: time structure and relationships with periodic leg movements during sleep. Ferri R; Manconi M; Plazzi G; Bruni O; Cosentino FI; Ferini-Strambi L; Zucconi M Sleep Med; 2012 May; 13(5):529-35. PubMed ID: 22341907 [TBL] [Abstract][Full Text] [Related]
10. Dissociation of periodic leg movements from arousals in restless legs syndrome. Manconi M; Ferri R; Zucconi M; Bassetti CL; Fulda S; Aricò D; Ferini-Strambi L Ann Neurol; 2012 Jun; 71(6):834-44. PubMed ID: 22718547 [TBL] [Abstract][Full Text] [Related]
11. Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome. Garcia-Borreguero D; Patrick J; DuBrava S; Becker PM; Lankford A; Chen C; Miceli J; Knapp L; Allen RP Sleep; 2014 Apr; 37(4):635-43. PubMed ID: 24899755 [TBL] [Abstract][Full Text] [Related]
12. Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease. Maestri M; Fulda S; Ferini-Strambi L; Zucconi M; Marelli S; Staedler C; Bassetti CL; Manconi M Sleep Med; 2014 May; 15(5):570-5. PubMed ID: 24767724 [TBL] [Abstract][Full Text] [Related]
13. PTPRD as a candidate druggable target for therapies for restless legs syndrome? Morais MA; Franco B; Holanda ASS; Simino LAP; Manconi M; Torsoni A; Esteves AM J Sleep Res; 2021 Aug; 30(4):e13216. PubMed ID: 33111449 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study. Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941 [TBL] [Abstract][Full Text] [Related]
15. Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome. Manconi M; Ferri R; Zucconi M; Oldani A; Giarolli L; Bottasini V; Ferini-Strambi L Mov Disord; 2011 Apr; 26(5):892-5. PubMed ID: 21370262 [TBL] [Abstract][Full Text] [Related]
16. Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome. Quiroz C; Gulyani S; Ruiqian W; Bonaventura J; Cutler R; Pearson V; Allen RP; Earley CJ; Mattson MP; Ferré S Neuropharmacology; 2016 Dec; 111():160-168. PubMed ID: 27600688 [TBL] [Abstract][Full Text] [Related]
17. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Picchietti DL; England SJ; Walters AS; Willis K; Verrico T J Child Neurol; 1998 Dec; 13(12):588-94. PubMed ID: 9881529 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study. Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J Sleep Med; 2006 Aug; 7(5):407-17. PubMed ID: 16815748 [TBL] [Abstract][Full Text] [Related]
19. The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model. Luo F; Li C; Ondo WG; Xu P; Xie W; Le W Sleep Med; 2011 Jan; 12(1):41-6. PubMed ID: 21044864 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin. Lee CS; Lee SD; Kang SH; Park HY; Yoon IY Eur J Neurol; 2014 Feb; 21(2):260-6. PubMed ID: 24267148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]